Rapporto sull’analisi delle dimensioni del mercato e delle quote del mercato Diagnostica dei trapianti | Previsioni 2031

  • Report Code : TIPRE00003076
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 150
Buy Now

Si stima che le dimensioni del mercato della diagnostica dei trapianti raggiungeranno 1.542,89 milioni di dollari entro il 2027 rispetto a 789,88 milioni di dollari nel 2018; si stima che crescerà a un CAGR del 7,9% nel periodo 2019-2027.

La diagnostica dei trapianti si riferisce ai test diagnostici condotti sugli organi destinati a essere trapiantati. Questi test vengono condotti prima o dopo il trapianto. Alcune delle tecniche comuni utilizzate nella diagnostica dei trapianti sono test molecolari basati su sequenze, test molecolari basati su PCR e test non molecolari in alcuni casi. La diagnostica del trapianto è un fattore essenziale nel trapianto di organi poiché evita ulteriori complicazioni che potrebbero verificarsi dopo una procedura di trapianto.

La crescita del mercato della diagnostica dei trapianti è attribuita alla crescente prevalenza delle malattie cardiovascolari e alla crescita significativa dell'industria della biotecnologia. Tuttavia, i costosi interventi chirurgici di trapianto di organi possono ostacolare la crescita del mercato.

Regioni redditizie per il mercato della diagnostica dei trapianti



Approfondimenti di mercato

Crescente prevalenza delle malattie cardiovascolari

Le malattie cardiovascolari sono la principale causa di morte in tutto il mondo. L'invecchiamento della popolazione mostra comunemente l'alterazione strutturale e funzionale dell'accumulo di vasi nel corso della loro vita. Pertanto, aumenta il rischio di sviluppare malattie cardiovascolari. Secondo l’American College of Cardiology, si afferma che la CVD contribuisce a quasi 800.000 decessi negli Stati Uniti, ovvero circa un decesso su tre. La malattia coronarica (CHD) contribuisce alla maggior parte dei decessi per malattie cardiovascolari, seguita poi da ictus e insufficienza cardiaca. A quasi oltre 90 milioni di americani viene diagnosticata una malattia cardiovascolare. Inoltre, si afferma che a livello globale le malattie cardiovascolari contribuiscono per circa il 31% a tutti i decessi e si prevede che il costo delle malattie cardiovascolari sarà di circa 1.044 miliardi di dollari entro il 2030.

 < /p>

Le malattie cardiovascolari rappresentano il 45,0% di tutti i decessi in Europa e il 37,0% di tutti i decessi nell'UE. Per questo motivo, è probabile che la necessità di diagnostica per il trapianto di organi favorisca il mercato durante il periodo di previsione.

Approfondimenti basati su prodotti e servizi

< p> Il mercato globale della diagnostica dei trapianti, basato su prodotti e servizi, è segmentato in strumenti, reagenti e strumenti. materiali di consumo e software e amp; Servizi. I reagenti & nel 2018, il segmento dei materiali di consumo è stato il segmento più ampio tra i sottosegmenti di prodotti e servizi nel mercato della diagnostica dei trapianti. Tuttavia, il segmento software & Si prevede che il segmento dei servizi testimonierà una crescita della domanda al CAGR più veloce del 9,6% nel corso del 2019-2027.

Approfondimenti basati sul tipo

Il Il mercato globale della diagnostica dei trapianti, in base alla tipologia, è segmentato in trapianto di organi solidi, trapianto di tessuti molli e trapianto di cellule staminali. Il segmento dei trapianti di organi solidi ha detenuto la quota maggiore del mercato della diagnostica dei trapianti nel 2018 e si prevede che continuerà a detenere il mercato più ampio durante il periodo di previsione.

Basato sulla tecnologia Approfondimenti

Il mercato globale della diagnostica dei trapianti, basato sulla tecnologia, è segmentato in saggi molecolari e saggi non molecolari. Nel 2018, il segmento dei sistemi di analisi molecolari deteneva una quota maggiore del mercato e si prevede che assisterà a una crescita della domanda a un CAGR più rapido del 9,5% nel corso del 2019-2027.

< h3>Approfondimenti basati sull'applicazione

Il mercato globale della diagnostica dei trapianti, in base all'applicazione, è segmentato in applicazioni diagnostiche e applicazioni di ricerca. Nel 2018, il segmento delle applicazioni diagnostiche ha detenuto una quota maggiore del mercato e si prevede che crescerà a un ritmo più rapido nei prossimi anni.

Approfondimenti strategici

Il lancio e l'approvazione dei prodotti sono strategie comunemente adottate dalle aziende per espandere la propria presenza globale e i propri portafogli di prodotti. Inoltre, gli attori del mercato della diagnostica dei trapianti si concentrano sulla strategia di partnership per ampliare la propria clientela, che, a sua volta, consente loro di mantenere il proprio marchio in tutto il mondo.

Azienda Profili

  • BIO-RAD LABORATORIES, INC
  • BIOMÉRIEUX SA
  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • QIAGEN NV
  • F. HOFFMANN-LA ROCHE LTD.
  • HOLOGIC INC.
  • LUMINEX CORPORATION
  • OMIXON INC.
  • ABBOTT
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are transplant diagnostics?

Transplant diagnostics refers to the diagnostics tests that are conducted on the organs that are meant to be transplanted. These tests are performed pre and post transplantation.

What are major common techniques used in transplant diagnostics?

Some of the common techniques used in transplant diagnostics include, sequence based molecular assays, and PCR based molecular assays and also non-molecular assays in certain cases.

Who are the key players in the transplant diagnostics market?

The major key players are Abbott, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Omixon Inc., Hologic Inc., Luminex Corporation, F. Hoffmann-La Roche Ltd, bioMérieux SA.

The List of Companies
  1. Thermo Fisher Scientific Inc.
  2. Abbott
  3. Illumina, Inc.
  4. F. Hoffmann-La Roche Ltd
  5. Bio-Rad Laboratories, Inc.
  6. bioMérieux SA
  7. QIAGEN
  8. Hologic Inc.
  9. Luminex Corporation
  10. Omixon Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports